IL7R and breast cancer: We next employed these specific gene signatures to investigate the prognostic impact of CD127+ CD39lo and CD127− CD39hi subsets of Trm cells on BC prognosis, as defined in the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) dataset34.